A carregar...
Teneligliptin As an Initial Therapy for Newly Diagnosed, Drug Naive Subjects With Type 2 Diabetes
BACKGROUND: Teneligliptin is a novel, highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor. The aim of this study is to explore the glycemic and non-glycemic efficacies of teneligliptin as an initial therapy. METHODS: Newly diagnosed, drug naive Japanese subjects with type 2 diabetes (T2DM) wer...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4039101/ https://ncbi.nlm.nih.gov/pubmed/24883155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr1841e |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|